Navigation Links
Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting
Date:9/2/2009

SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Results from studies related to Optimer Pharmaceuticals, Inc.'s (Nasdaq: OPTR) lead developmental product candidates will be presented at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) to be held at The Moscone Center in San Francisco on September 12-15, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090413/LA97352LOGO)

    Fidaxomicin abstracts and speakers include:

    "Low Recurrence Rate among Patients with C. difficile Infection (CDI)
    Treated with Fidaxomicin (FDX)"
    Poster Presentation: Yoav Golan, M.D., M.S.
    Monday, September 14, 2009 11:15am-1:15pm Pacific Time
    Presentation number: L1-1639 in Hall B

    "Restriction Endonuclease Analysis (REA) Typing of Clostridium difficile
    in a Phase 3 Treatment Trial of Fidaxomicin vs Vancomycin: Decreased Cure
    Rate for Epidemic BI/NAP1/027 Strain"
    Poster Presentation: Dale N. Gerding, M.D.
    Monday, September 14, 2009 11:15am-1:15pm Pacific Time
    Presentation number: L1-1642 in Hall B

    "Comparative Fidaxomicin Susceptibilities of Isolates Collected at
    Baseline, Failure, and Recurrence from Patients in a Phase III Trial of
    Clostridium difficile Infection (CDI)"
    Poster Presentation: Ellie J. Goldstein, M.D.
    Monday, September 14, 2009 11:15am-1:15pm Pacific Time
    Presentation number: L1-1641 in Hall B

    "Safety of Fidaxomicin Versus Vancomycin in Treatment of Clostridium
    difficile Infection"
    Poster Presentation: Sherwood L. Gorbach, M.D.
    Monday, September 14, 2009 11:15am-1:15pm Pacific Time
    Presenta
'/>"/>
SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
2. Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI
3. Optimer Pharmaceuticals to Present at June 2009 Investor Conferences
4. Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference
5. Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , ... August 31, 2015 , ... ... a high priority in the drug development approval process. Thus, innovator companies must ... year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting multiple educational panels ...
(Date:8/31/2015)... ... August 31, 2015 , ... Proove Biosciences, Inc. is ... Alliance Annual High Tech Awards. , Now in its 22nd year, this premier ... drive innovation here, across the nation and around the world. The OC Tech Alliance ...
(Date:8/28/2015)... -- According to a new market research ... Thawing Equipment, Alarms), by Biospecimen (Human Tissue, Stem Cells, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Million by 2020 from USD 2,150.48 Million in 2015, ... 2020. Browse 74 Tables and 95 ...
(Date:8/28/2015)... , Aug. 28, 2015 /PRNewswire/ - RepliCel Life ... regenerative medicine company focused on the development of ... the quarter ended June 30, 2015, corporate highlights, ... management report are available at www.sedar.com ,  ... "RepliCel expects to launch its ...
Breaking Biology Technology:Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5
... /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-,pharmaceutical Technology Inc. (OTC Bulletin ... extracts and pharmaceutical raw materials,for use in pharmaceutical, ... 15 that it has established a strategic alliance ... will focus on,corporate imaging and creating retail market ...
... Mass., July 16 U.S. Genomics today announced,the ... U.S. Department of Homeland,Security (DHS) Science and Technology ... Networked Detectors (BAND) program will,enable U.S. Genomics to ... biological sensor for the detection of airborne,pathogens using ...
... Diego School of Medicine researcher has developed the first ... model infection with the Hepatitis C virus (HCV) and ... The novel cell line, described in the July 16 ... companies to effectively test new drug candidates or possible ...
Cached Biology Technology:Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc. 2Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc. 3U.S. Genomics Awarded $9.1 Million Contract for Development of Advanced Biosensor by the U.S. Department of Homeland Security 2Improved culture system for hepatitis C virus infection 2
(Date:8/5/2015)... According to a new market research report, ... (BFSI, Airport, IT & Telecom, Utilities, Education, Defense & ... published by MarketsandMarkets, defines and segments the Physical Identity ... global PIAM Market is estimated to grow from $272.2 ... a CAGR of 14.9 % from 2014 to 2019. ...
(Date:8/4/2015)... 2015 Research ... the addition of the "Digital Forensics ... Sub-Segment (Computer Forensics, Network Forensics, Mobile Device ... Vertical and Region - Global Forecast to ... By Component (Hardware, Software, and Service), ...
(Date:7/31/2015)... juli 2015 Den 10. internationale konference om ... den 22. - 25. oktober i Shenzhen ... 10-års fødselsdag i år. Siden starten i 2006 er ... på ,omik,-feltet, og er en af de mest dynamiske, ... fokuserer på nylige gennembrud og fremskridt inden for ,omik,-forskning, ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... prediction program by computer scientists at Washington University in ... beginnings of gene transcription start sites and where the ... the gene. , The modification to the gene prediction ... of computer science at Washington University in St. Louis, ...
... effects of climate change on rainforests is being investigated ... shape of epiphytes ('air-plants' which grow on other plants) ... have been affected by climate change over the last ... bromeliads, Monica Mejia-Chang from Professor Howard Griffiths' lab in ...
... human genes has begun at the European Molecular ... the MitoCheck consortium that includes 10 other institutes ... human genes, one-by-one, to find those involved in ... of how cell division is regulated. , The ...
Cached Biology News:Modification of program enables prediction of gene transcription 2Modification of program enables prediction of gene transcription 3Hunt for human genes involved in cell division under way 2
... the leading provider of X-ray crystallography ... fragment-based screening services to its pharmaceutical ... the binding of drug-like fragments to ... drug targets, allowing scientists to develop ...
Large-capacity refrigerated incubator chamber holds up to 4 independently-operated shakers. Programmable heat, refrigeration, humidifcation are standard. Photosynthetic operation, optional....
... >95%NEN Radiolabeled Ligands\n\nReceptor-related research has long been ... radiolabeled ligands selected to keep pace with ... of products and services for receptor research ... radioligands. If you do not find exactly ...
Denhardt's powder mixture (for 50X stock solution)...
Biology Products: